Lower Exposure to Busulfan Allows for Stable Engraftment of Donor Hematopoietic Stem Cells in Children with Mucopolysaccharidosis Type I: A Case Report of Four Patients

Busulfan is an alkylating agent routinely used in conditioning regimens prior to allogeneic hematopoietic cell transplantation (HCT) for various nonmalignant disorders, including inborn errors of metabolism. The combination of model-based dosing and therapeutic drug monitoring (TDM) of busulfan phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Praveen, Dvorak, Christopher C., Long-Boyle, Janel, Kharbanda, Sandhya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460609/
https://www.ncbi.nlm.nih.gov/pubmed/32781600
http://dx.doi.org/10.3390/ijms21165634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460609/
https://www.ncbi.nlm.nih.gov/pubmed/32781600
http://dx.doi.org/10.3390/ijms21165634

Ejemplares similares